Nonadherence to Cancer Screening Varies by Screening Type
THURSDAY, Jan. 9, 2025 -- Nonadherence to cancer screening varies by screening type and sex, according to a study published online Jan. 3 in JAMA Network Open.
Ami E. Sedani, Ph.D., M.P.H., from the University of Texas Health Sciences Center at Houston, and colleagues examined the associations between individual-level social risks and nonadherence to guideline-recommended cancer screenings in a cross-sectional study using 2022 Behavioral Risk Factor Surveillance System data from 39 U.S. states and Washington, D.C.
The analysis included 147,922 individuals, representing a weighted sample of 78,784,149 U.S. adults. The researchers found that life dissatisfaction was associated with nonadherence for cervical cancer screening (CCS) and breast cancer screening (BCS). There was an association for lack of support with nonadherence to colorectal cancer screening (CRCS) in men and women and nonadherence to BCS; feeling isolated was associated with nonadherence to CRCS in women and nonadherence to BCS. In nonadherence to BCS, there was an association with feeling mentally distressed. Food insecurity was associated with an increased risk for CRCS nonadherence in men and women and with CCS and BCS nonadherence. The direction of lung cancer screening (LCS) effect sizes were the same, but they were not statistically significant. Transportation insecurity was associated with nonadherence to CRCS in women and nonadherence to BCS, while increased risks for CRCS nonadherence in men and women, LCS nonadherence in women, and BCS nonadherence were seen in association with cost barriers in health care access.
"Further research targeting specific populations is essential before effective interventions can be implemented, as social risks may not always align with patient-centered social needs," the authors write.
One author disclosed ties to Exact Sciences.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Features of Immunesenescence Present in Early Stages of Rheumatoid Arthritis
THURSDAY, Sept. 11, 2025 -- Some features of immunesenescence are present in the very early stages of rheumatoid arthritis (RA), according to a study published online Sept. 3 in...
Urine Biomarker Panel Sensitive, Specific for Prostate Cancer Diagnosis
THURSDAY, Sept. 11, 2025 -- A urine-based biomarker panel has high accuracy for diagnosing prostate cancer (PCa), according to a study published in the September issue of...
Hospitals Vary in Their Definition of Blood Culture Contamination
THURSDAY, Sept. 11, 2025 -- U.S. hospitals vary in how they define blood culture contamination (BCC), according to a study published online July 11 in the Journal of Clinical...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.